Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Option Care Health (OPCH) Shares Outstanding (Weighted Average) (2016 - 2026)

Option Care Health (OPCH) has disclosed Shares Outstanding (Weighted Average) for 18 consecutive years, with $156.7 million as the latest value for Q1 2026.

  • For Q1 2026, Shares Outstanding (Weighted Average) fell 5.32% year-over-year to $156.7 million; the TTM value through Mar 2026 reached $156.7 million, down 5.32%, while the annual FY2025 figure was $162.1 million, 5.52% down from the prior year.
  • Shares Outstanding (Weighted Average) hit $156.7 million in Q1 2026 for Option Care Health, down from $162.1 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $181.9 million in Q3 2022 and bottomed at $156.7 million in Q1 2026.
  • Average Shares Outstanding (Weighted Average) over 5 years is $173.3 million, with a median of $173.9 million recorded in 2024.
  • Year-over-year, Shares Outstanding (Weighted Average) increased 1.14% in 2022 and then fell 5.52% in 2025.
  • Option Care Health's Shares Outstanding (Weighted Average) stood at $181.1 million in 2022, then decreased by 1.18% to $179.0 million in 2023, then fell by 4.14% to $171.6 million in 2024, then decreased by 5.52% to $162.1 million in 2025, then decreased by 3.36% to $156.7 million in 2026.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $156.7 million, $162.1 million, and $163.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.